Emerging pharmacotherapies for obesity: A systematic review US$ 26.38 Min. order: 1 piece ★★★★★ 4.9 (49 reviews) Sold : Login>>
Incretin-based investigational therapies for the treatment of MASLD/MASH US$ 20.46 Min. order: 1 piece ★★★★★ 4.9 (46 reviews) Sold : Login>>
PDF] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 23.22 Min. order: 1 piece ★★★★★ 4.5 (285 reviews) Sold : Login>>